FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

John Morrow

Research Profile

Chemicals & Drugs

Living Beings

Anatomy

Procedures

Vaccination

Physiology

Disorders

HIV Infections

Co-author Network

Publications

TOP 3
Li Liang; Xiaowu Liang; Douglas Molina; W John W Morrow; Rie Nakajima-Sasaki; Jozelyn Pablo; Mayuko Saito; Xiaolin Tan; Renée M Tsolis; Homarh Villaverde; Joseph M Vinetz; Scott Felgner; Robert H Gilman; Eduardo Gotuzzo; Gary Hermanson; Silvia Juarez; D Huw Davies; Philip L Felgner
Systems biology approach predicts antibody signature associated with Brucella melitensis infection in humans.
Li Liang; Diana Leng; Chad Burk; Rie Nakajima-Sasaki; Matthew A Kayala; Vidya L Atluri; Jozelyn Pablo; Berkay Unal; Thomas A Ficht; Eduardo Gotuzzo; Mayuko Saito; W John W Morrow; Xiaowu Liang; Pierre Baldi; Robert H Gilman; Joseph M Vinetz; Renée M Tsolis; Philip L Felgner
Large scale immune profiling of infected humans and goats reveals differential recognition of Brucella melitensis antigens.
Raymond L Houghton; Yvonne Y Stevens; Kathryn Hjerrild; Jeff Guderian; Masahiko Okamoto; Mazbahul Kabir; Steven G Reed; David A Leiby; W John W Morrow; Myriam Lorca; Syamal Raychaudhuri
Lateral flow immunoassay for diagnosis of Trypanosoma cruzi infection with high correlation to the radioimmunoprecipitation assay.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of John Morrow (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Li Liang; Xiaowu Liang; Douglas Molina; W John W Morrow; Rie Nakajima-Sasaki; Jozelyn Pablo; Mayuko Saito; Xiaolin Tan; Renée M Tsolis; Homarh Villaverde; Joseph M Vinetz; Scott Felgner; Robert H Gilman; Eduardo Gotuzzo; Gary Hermanson; Silvia Juarez; D Huw Davies; Philip L Felgner
Systems biology approach predicts antibody signature associated with Brucella melitensis infection in humans.
Journal of proteome research 2011;10(10):4813-24.
2010: Li Liang; Diana Leng; Chad Burk; Rie Nakajima-Sasaki; Matthew A Kayala; Vidya L Atluri; Jozelyn Pablo; Berkay Unal; Thomas A Ficht; Eduardo Gotuzzo; Mayuko Saito; W John W Morrow; Xiaowu Liang; Pierre Baldi; Robert H Gilman; Joseph M Vinetz; Renée M Tsolis; Philip L Felgner
Large scale immune profiling of infected humans and goats reveals differential recognition of Brucella melitensis antigens.
PLoS neglected tropical diseases 2010;4(5):e673.
2009: Raymond L Houghton; Yvonne Y Stevens; Kathryn Hjerrild; Jeff Guderian; Masahiko Okamoto; Mazbahul Kabir; Steven G Reed; David A Leiby; W John W Morrow; Myriam Lorca; Syamal Raychaudhuri
Lateral flow immunoassay for diagnosis of Trypanosoma cruzi infection with high correlation to the radioimmunoprecipitation assay.
Clinical and vaccine immunology : CVI 2009;16(4):515-20.
2007: Clint S Schmidt; W John W Morrow; Nadeem A Sheikh
Smart adjuvants.
Expert review of vaccines 2007;6(3):391-400.
2005: Karen E Isherwood; Richard Titball; D Huw Davies; Philip L Felgner; W John W Morrow
Vaccination strategies for Francisella tularensis.
Advanced drug delivery reviews 2005;57(9):1403-14.
2004: Caterina Hatzifoti; Mona Bajaj-Elliott; Nick Dorrell; Martin Anyim; Michael B Prentice; Keith Nye; Brendan Wren; W John W Morrow
A plasmid immunization construct encoding urease B of Helicobacter pylori induces an antigen-specific antibody response and upregulates the expression of beta-defensins and IL-10 in the stomachs of immunized mice.
Vaccine 2004;22(20):2651-9.
2004: W John W Morrow; Ya-Wun Yang; Nadeem A Sheikh
Immunobiology of the Tomatine adjuvant.
Vaccine 2004;22(19):2380-4.
2004: Ya-Wun Yang; Ching-An Wu; W John W Morrow
The apoptotic and necrotic effects of tomatine adjuvant.
Vaccine 2004;22(17-18):2316-27.
2004: Ya-Wun Yang; Ching-An Wu; W John W Morrow
Cell death induced by vaccine adjuvants containing surfactants.
Vaccine 2004;22(11-12):1524-36.
2003: Nadeem A Sheikh; W John W Morrow
Guns, genes, and spleen: a coming of age for rational vaccine design.
Methods (San Diego, Calif.) 2003;31(3):183-92.
2003: Nadeem A Sheikh; George S Attard; Nico van Rooijen; Palasingam Rajananthanan; Kandasamy Hariharan; Ya-Wun Yang; W John W Morrow
Differential requirements for CTL generation by novel immunostimulants: APC tropism, use of the TAP-independent processing pathway, and dependency on CD80/CD86 costimulation.
Vaccine 2003;21(25-26):3775-88.
2003: Nasir Torabi-Pour; W John W Morrow; Roghieh Saffie; Prashanth Govinde Gowda; D Perrett; Timothy R D Oliver
Identification and quantification of antigens associated with HLA class I molecules on a bladder tumour cell line. Implications for vaccine design.
Urologia internationalis 2003;70(3):154-60.
2002: Ya-Wun Yang; Nadeem A Sheikh; W John W Morrow
The ultrastructure of tomatine adjuvant.
Biomaterials 2002;23(23):4677-86.
2002: UA Hasan; DR Harper; Brendan W Wren; W John W Morrow
Immunization with a DNA vaccine expressing a truncated form of varicella zoster virus glycoprotein E.
Vaccine 2002;20(9-10):1308-15.
2002: Nasir Torabi-Pour; A M E Nouri; Roghieh Saffie; W John W Morrow; R T D Oliver
Isolation of human leukocyte antigen (HLA)-associated peptide(s) in the absence of HLA-restricted specific cytolytic T lymphocytes.
Urologia internationalis 2002;69(3):219-26.
2001: Karen G Heal; Nadeem A Sheikh; Michael R Hollingdale; W John W Morrow; Andrew W Taylor-Robinson
Potentiation by a novel alkaloid glycoside adjuvant of a protective cytotoxic T cell immune response specific for a preerythrocytic malaria vaccine candidate antigen.
Vaccine 2001;19(30):4153-61.
2001: Elizabeth C Jury; David D'Cruz; W John W Morrow
Autoantibodies and overlap syndromes in autoimmune rheumatic disease.
Journal of clinical pathology 2001;54(5):340-7.
2000: Caterina Hatzifoti; Brendan W Wren; W John W Morrow
Helicobacter pylori vaccine strategies--triggering a gut reaction.
Immunology today 2000;21(12):615-9.
2000: E L Ross; David D'Cruz; W John W Morrow
Localized monocyte chemotactic protein-1 production correlates with T cell infiltration of synovium in patients with psoriatic arthritis.
The Journal of rheumatology 2000;27(10):2432-43.
2000: UA Hasan; DR Harper; S Argent; Guy T Layton; Brendan W Wren; W John W Morrow
Immunization with a DNA expression vector encoding the varicella zoster virus glycoprotein E (gE) gene via intramuscular and subcutaneous routes.
Vaccine 2000;18(15):1506-14.
2000: Nadeem A Sheikh; M al-Shamisi; W John W Morrow
Delivery systems for molecular vaccination.
Current opinion in molecular therapeutics 2000;2(1):37-54.
1999: UA Hasan; A M Abai; DR Harper; Brendan W Wren; W John W Morrow
Nucleic acid immunization: concepts and techniques associated with third generation vaccines.
Journal of immunological methods 1999;229(1-2):1-22.
1999: Palasingam Rajananthanan; George S Attard; Nadeem A Sheikh; W John W Morrow
Novel aggregate structure adjuvants modulate lymphocyte proliferation and Th1 and Th2 cytokine profiles in ovalbumin immunized mice.
Vaccine 1999;18(1-2):140-52.
1999: Nadeem A Sheikh; Palasingam Rajananthanan; George S Attard; W John W Morrow
Generation of antigen specific CD8+ cytotoxic T cells following immunization with soluble protein formulated with novel glycoside adjuvants.
Vaccine 1999;17(23-24):2974-82.
1999: J Kayaga; BE Souberbielle; Nadeem A Sheikh; W John W Morrow; TH Scott-Taylor; Richard Vile; Heung Chong; Angus G Dalgleish
Anti-tumour activity against B16-F10 melanoma with a GM-CSF secreting allogeneic tumour cell vaccine.
Gene therapy 1999;6(8):1475-81.
1999: Palasingam Rajananthanan; George S Attard; Nadeem A Sheikh; W John W Morrow
Evaluation of novel aggregate structures as adjuvants: composition, toxicity studies and humoral responses.
Vaccine 1999;17(7-8):715-30.
1999: Tony Ng; I E Collins; SB Kanner; Martin J Humphries; N Amft; RG Wickremasinghe; David D'Cruz; Keith Nye; W John W Morrow
Integrin signalling defects in T-lymphocytes in systemic lupus erythematosus.
Lupus 1999;8(1):39-51.
1998: BE Souberbielle; M Westby; S Ganz; J Kayaga; R Mendes; W John W Morrow; Angus G Dalgleish
Comparison of four strategies for tumour vaccination in the B16-F10 melanoma model.
Gene therapy 1998;5(11):1447-54.
1998: E L Ross; David D'Cruz; W John W Morrow
Pathogenic mechanisms in psoriatic arthritis.
Hospital medicine (London, England : 1998) 1998;59(7):534-8.
1997: Tony Ng; F A Gibson; Keith Nye; P J Hughes; Charles J Hinds; W John W Morrow; C Ferguson
Desensitization of the inflammatory response in humans: changes in response to cardiopulmonary bypass.
Shock (Augusta, Ga.) 1997;8(3):159-64.
1997: Tony Ng; SB Kanner; Martin J Humphries; RG Wickremasinghe; Keith Nye; J Anderson; W John W Morrow
Dysfunctional focal adhesion kinase (pp125FAK) expression in HIV-infected donor T-cells.
Biochemical Society transactions 1997;25(2):219S.
1997: Tony Ng; SB Kanner; Martin J Humphries; RG Wickremasinghe; Keith Nye; J Anderson; S H Khoo; W John W Morrow
The integrin-triggered rescue of T lymphocyte apoptosis is blocked in HIV-1-infected individuals.
Journal of immunology (Baltimore, Md. : 1950) 1997;158(6):2984-99.
1996: Tony Ng; A J Pinching; Christine Guntermann; W John W Morrow
Molecular immunopathogenesis of HIV infection.
Genitourinary medicine 1996;72(6):408-18.
1996: BE Souberbielle; B C Knight; W John W Morrow; D Darling; M Fraziano; J Blake Marriott; S Cookson; Farzin Farzaneh; Angus G Dalgleish
Comparison of IL-2- and IL-4-transfected B16-F10 cells with a novel oil-microemulsion adjuvant for B16-F10 whole cell tumour vaccine.
Gene therapy 1996;3(10):853-8.
1995: Tony Ng; Christine Guntermann; Keith Nye; J M Parkin; J Anderson; J E Norman; W John W Morrow
Adhesion co-receptor expression and intracellular signalling in HIV disease: implications for immunotherapy.
AIDS (London, England) 1995;9(4):337-43.